QUOTRELUS Trademark

Trademark Overview

On Tuesday, January 22, 2019, a trademark application was filed for QUOTRELUS with the United States Patent and Trademark Office. The USPTO has given the QUOTRELUS trademark a serial number of 88271045. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 12, 2022. This trademark is owned by Glaxo Group Limited. The QUOTRELUS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
quotrelus

General Information

Serial Number88271045
Word MarkQUOTRELUS
Filing DateTuesday, January 22, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 12, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 10, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 14, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Monday, December 12, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 12, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, April 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 25, 2022SOU EXTENSION 5 GRANTED
Wednesday, April 20, 2022SOU EXTENSION 5 FILED
Wednesday, April 20, 2022SOU TEAS EXTENSION RECEIVED
Friday, October 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 14, 2021SOU EXTENSION 4 GRANTED
Wednesday, October 6, 2021SOU EXTENSION 4 FILED
Thursday, October 14, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 6, 2021SOU TEAS EXTENSION RECEIVED
Thursday, April 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 13, 2021SOU EXTENSION 3 GRANTED
Tuesday, April 13, 2021SOU EXTENSION 3 FILED
Tuesday, April 13, 2021SOU TEAS EXTENSION RECEIVED
Friday, October 2, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 30, 2020SOU EXTENSION 2 GRANTED
Wednesday, September 30, 2020SOU EXTENSION 2 FILED
Wednesday, September 30, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, February 12, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 10, 2020SOU EXTENSION 1 GRANTED
Monday, February 10, 2020SOU EXTENSION 1 FILED
Monday, February 10, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, November 5, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 10, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 10, 2019PUBLISHED FOR OPPOSITION
Wednesday, August 21, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 8, 2019ASSIGNED TO LIE
Sunday, July 28, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 11, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 11, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 11, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 1, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 1, 2019NON-FINAL ACTION E-MAILED
Friday, March 1, 2019NON-FINAL ACTION WRITTEN
Friday, March 1, 2019ASSIGNED TO EXAMINER
Thursday, February 14, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 25, 2019NEW APPLICATION ENTERED

Related Keywords

quotrelus pharmaceutical treatment preparations diseases disorders substances respiratory oncological genitourinary neurological